• Profile
Close

Use and outcomes of cerebral embolic protection for transcatheter aortic valve replacement: A US nationwide study

Catheterization and Cardiovascular Interventions Jun 24, 2021

Khan MZ, Zahid S, Khan MU, et al. - Given limited outcomes data exist regarding the use of cerebral embolic protection devices (CPDs) with transcatheter aortic valve replacement (TAVR), therefore, researchers herein used the National Inpatient Sample and Nationwide Readmissions Database to analyze utilization and inpatient mortality, neurological complications (ischemic stroke, hemorrhagic stroke, and transient ischemic attack), procedural complications, resource utilization, as well as 30-day readmissions with and without use of CPD. They developed a 1:3 ratio propensity score matched model. This work provides real-world data regarding utilization and in-hospital results of CPD use in TAVR. Findings revealed that lower inpatient mortality, neurological, and clinical complications were observed in relation to CPD use vs TAVR without CPD.

Go to Original
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
  • Exclusive Write-ups & Webinars by KOLs

  • Nonloggedininfinity icon
    Daily Quiz by specialty
  • Nonloggedinlock icon
    Paid Market Research Surveys
  • Case discussions, News & Journals' summaries
Sign-up / Log In
x
M3 app logo
Choose easy access to M3 India from your mobile!


M3 instruc arrow
Add M3 India to your Home screen
Tap  Chrome menu  and select "Add to Home screen" to pin the M3 India App to your Home screen
Okay